Electrical Impedance Tomography for Quantification of Pulmonary Edema in Acute Respiratory Distress Syndrome Patients

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

22 participants

Study Classification

OBSERVATIONAL

Study Start Date

2016-08-31

Study Completion Date

2017-08-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Evaluation of pulmonary edema is a key factor in monitoring and guidance of therapy in acute respiratory distress syndrome (ARDS) patients. To date, methods available at the bedside for estimating the physiologic correlate of pulmonary edema, extravascular lung water(EVLW), often are unreliable or require invasive measurements. The purpose of the this study is to develop a novel approach to reliably assess extravascular lung water by electrical impedance tomography(EIT).

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Determine the Effect of Prone Positioning in Adults With ARDS by Electrical Impedance Tomography

NCT04725227

ARDS Prone Position Electrical Impedance Tomography

UNKNOWN

Electrical Impedance Tomography-Based Prognostic Model for ARDS

NCT06967207

Acute Respiratory Distress Syndrome (ARDS) Ventilator-induced Lung Injury

RECRUITING

Effect of EIT-guided PEEP Titration on the Prognosis of Patients with Moderate to Severe ARDS

NCT05207202

Clinical Outcomes

COMPLETED NA

Post- End- Expiratory Pressure Affect the Alveolar Heterogeneity in Moderate and Sever ARDS Patients

NCT03763890

Ards

UNKNOWN

Electrical Impedance Tomography (EIT) Monitoring in Adults With ALI or ARDS

NCT01272882

Acute Lung Injury (ALI) ARDS

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Acute Respiratory Distress Syndrome

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Study Time Perspective

CROSS_SECTIONAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

Patients will be included in this study if the following criteria have been met:

1. Males and females \> 18 years old and \<85 years old (non-pregnant, non-lactating females).
2. Patients fulfilled the Berlin diagnostic criteria of ARDS
3. Signed written informed consent has been obtained
4. Patients had monitoring system Pulse-Induced Contour Cardiac Output (PiCCO)

Exclusion Criteria

1. Females who are pregnant or lactating.
2. Patients with contraindication of EIT(Skin abrasions or wounds in the chest area.Patients with pacemakers or paced EKG rhythms.Thoracic deformity. Severe subcutaneous emphysema)
3. Patients \<18 years old or \> 85 years old
4. Patients Without monitoring system Pulse-Induced Contour Cardiac Output (PiCCO)
5. Patients with Cardiac function of grade 4 or patients with acute myocardial infarction or acute coronary syndrome

Minimum Eligible Age

18 Years

Maximum Eligible Age

85 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No